TY - JOUR AU - Citron, M. PY - 2010 DA - 2010// TI - Alzheimer’s disease: strategies for disease modification JO - Nat Rev Drug Discov VL - 9 UR - https://doi.org/10.1038/nrd2896 DO - 10.1038/nrd2896 ID - Citron2010 ER - TY - JOUR AU - Sperling, R. A. AU - Aisen, P. S. AU - Beckett, L. A. AU - Bennett, D. A. AU - Craft, S. AU - Fagan, A. M. PY - 2011 DA - 2011// TI - Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.003 DO - 10.1016/j.jalz.2011.03.003 ID - Sperling2011 ER - TY - JOUR AU - Vassar, R. AU - Bennett, B. D. AU - Babu-Khan, S. AU - Kahn, S. AU - Mendiaz, E. A. AU - Denis, P. PY - 1999 DA - 1999// TI - Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE JO - Science VL - 286 UR - https://doi.org/10.1126/science.286.5440.735 DO - 10.1126/science.286.5440.735 ID - Vassar1999 ER - TY - JOUR AU - Sinha, S. AU - Anderson, J. P. AU - Barbour, R. AU - Basi, G. S. AU - Caccavello, R. AU - Davis, D. PY - 1999 DA - 1999// TI - Purification and cloning of amyloid precursor protein beta-secretase from human brain JO - Nature VL - 402 UR - https://doi.org/10.1038/990114 DO - 10.1038/990114 ID - Sinha1999 ER - TY - JOUR AU - Mulder, S. D. AU - van der Flier, W. M. AU - Verheijen, J. H. AU - Mulder, C. AU - Scheltens, P. AU - Blankenstein, M. A. PY - 2010 DA - 2010// TI - BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology JO - J Alzheimers Dis VL - 20 UR - https://doi.org/10.3233/JAD-2010-1367 DO - 10.3233/JAD-2010-1367 ID - Mulder2010 ER - TY - JOUR AU - Zetterberg, H. AU - Andreasson, U. AU - Hansson, O. AU - Wu, G. AU - Sankaranarayanan, S. AU - Andersson, M. E. PY - 2008 DA - 2008// TI - Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease JO - Arch Neurol VL - 65 UR - https://doi.org/10.1001/archneur.65.8.1102 DO - 10.1001/archneur.65.8.1102 ID - Zetterberg2008 ER - TY - JOUR AU - Zhong, Z. AU - Ewers, M. AU - Teipel, S. AU - Burger, K. AU - Wallin, A. AU - Blennow, K. PY - 2007 DA - 2007// TI - Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment JO - Arch Gen Psychiatry VL - 64 UR - https://doi.org/10.1001/archpsyc.64.6.718 DO - 10.1001/archpsyc.64.6.718 ID - Zhong2007 ER - TY - JOUR AU - Timmers, M. AU - Barao, S. AU - Van Broeck, B. AU - Tesseur, I. AU - Slemmon, J. AU - De Waepenaert, K. PY - 2017 DA - 2017// TI - BACE1 dynamics upon inhibition with a BACE inhibitor and correlation to downstream Alzheimer’s disease markers in elderly healthy participants JO - J Alzheimers Dis VL - 56 UR - https://doi.org/10.3233/JAD-160829 DO - 10.3233/JAD-160829 ID - Timmers2017 ER - TY - JOUR AU - Timmers, M. AU - Van Broeck, B. AU - Ramael, S. AU - Slemmon, J. AU - De Waepenaert, K. AU - Russu, A. AU - Bogert, J. M. AU - Stieltjes, H. AU - Shaw, L. M. AU - Engelborghs, S. AU - Moechars, D. AU - Mercken, M. AU - Liu, E. AU - Sinha, V. AU - Kemp, J. AU - Van Nueten, L. AU - Tritsmans, L. AU - Streffer, J. R. PY - 2016 DA - 2016// TI - Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor JO - Alzheimers Dement VL - 2 ID - Timmers2016 ER - TY - JOUR AU - Liu, X. AU - Wong, H. AU - Scearce-Levie, K. AU - Watts, R. J. AU - Coraggio, M. AU - Shin, Y. G. PY - 2013 DA - 2013// TI - Mechanistic pharmacokinetic-pharmacodynamic modeling of BACE1 inhibition in monkeys: development of a predictive model for amyloid precursor protein processing JO - Drug Metab Dispos VL - 41 UR - https://doi.org/10.1124/dmd.112.050864 DO - 10.1124/dmd.112.050864 ID - Liu2013 ER - TY - STD TI - Beal SL, Boeckmann AJ, Bauer RJ, editors. NONMEM 7.2.0 users guides. Ellicott City: Icon Development Solutions; 1989–2011. ID - ref11 ER - TY - STD TI - Timmerman P, White S, Dougall SM, Kall MA, Smeraglia J, Fjording MS, et al. Tiered approach into practice: scientific validation for chromatography-based assays in early development - a recommendation from the European bioanalysis forum. Bioanalysis 2015;7(18):2387–98. ID - ref12 ER - TY - JOUR AU - Struyfs, H. AU - Van Broeck, B. AU - Timmers, M. AU - Fransen, E. AU - Sleegers, K. AU - Van Broeckhoven, C. PY - 2015 DA - 2015// TI - Diagnostic accuracy of cerebrospinal fluid amyloid-beta isoforms for early and differential dementia diagnosis JO - J Alzheimers Dis VL - 45 UR - https://doi.org/10.3233/JAD-141986 DO - 10.3233/JAD-141986 ID - Struyfs2015 ER - TY - STD TI - Van Broeck B, Borgers M, Meulders G, Hermans B, Dhuyvetter D, Borghys H, Mercken M. Simultaneous evaluation of Aβ1-37/38/40/42 levels after treatment with secretase inhibitors and modulators using a novel immunoassay [abstract]. Neurodegener Dis. 2013;11(Suppl 1) ID - ref14 ER - TY - JOUR AU - Barao, S. AU - Zhou, L. AU - Adamczuk, K. AU - Vanhoutvin, T. AU - van Leuven, F. AU - Demedts, D. PY - 2013 DA - 2013// TI - BACE1 levels correlate with phospho-tau levels in human cerebrospinal fluid JO - Curr Alzheimer Res VL - 10 UR - https://doi.org/10.2174/15672050113109990138 DO - 10.2174/15672050113109990138 ID - Barao2013 ER - TY - JOUR AU - Lewczuk, P. AU - Kamrowski-Kruck, H. AU - Peters, O. AU - Heuser, I. AU - Jessen, F. AU - Popp, J. PY - 2010 DA - 2010// TI - Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer’s disease: a multicenter study JO - Mol Psychiatry VL - 15 UR - https://doi.org/10.1038/mp.2008.84 DO - 10.1038/mp.2008.84 ID - Lewczuk2010 ER - TY - JOUR AU - Palmqvist, S. AU - Zetterberg, H. AU - Blennow, K. AU - Vestberg, S. AU - Andreasson, U. AU - Brooks, D. J. PY - 2014 DA - 2014// TI - Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography JO - JAMA Neurol VL - 71 UR - https://doi.org/10.1001/jamaneurol.2014.1358 DO - 10.1001/jamaneurol.2014.1358 ID - Palmqvist2014 ER - TY - JOUR AU - Donohue, M. C. AU - Sperling, R. A. AU - Petersen, R. AU - Sun, C. K. AU - Weiner, M. W. AU - Aisen, P. S. PY - 2017 DA - 2017// TI - Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons JO - JAMA VL - 317 UR - https://doi.org/10.1001/jama.2017.6669 DO - 10.1001/jama.2017.6669 ID - Donohue2017 ER - TY - JOUR AU - Insel, P. S. AU - Mattsson, N. AU - Mackin, R. S. AU - Scholl, M. AU - Nosheny, R. L. AU - Tosun, D. PY - 2016 DA - 2016// TI - Accelerating rates of cognitive decline and imaging markers associated with beta-amyloid pathology JO - Neurology VL - 86 UR - https://doi.org/10.1212/WNL.0000000000002683 DO - 10.1212/WNL.0000000000002683 ID - Insel2016 ER - TY - JOUR AU - Salloway, S. AU - Sperling, R. AU - Fox, N. C. AU - Blennow, K. AU - Klunk, W. AU - Raskind, M. PY - 2014 DA - 2014// TI - Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1304839 DO - 10.1056/NEJMoa1304839 ID - Salloway2014 ER - TY - JOUR AU - Doody, R. S. AU - Thomas, R. G. AU - Farlow, M. AU - Iwatsubo, T. AU - Vellas, B. AU - Joffe, S. PY - 2014 DA - 2014// TI - Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1312889 DO - 10.1056/NEJMoa1312889 ID - Doody2014 ER - TY - JOUR AU - Yan, R. PY - 2016 DA - 2016// TI - Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs JO - Transl Neurodegener VL - 5 UR - https://doi.org/10.1186/s40035-016-0061-5 DO - 10.1186/s40035-016-0061-5 ID - Yan2016 ER - TY - STD TI - Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, et al. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease. N Engl J Med. 2018;378:1691–703. ID - ref23 ER -